ANIP
Companies
NASDAQ
Ani Pharmaceuticals Inc.
Health Care
$66.05
+$10.77 (+19.48%)
Price Chart
Overview
About ANIP
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Market Cap
$1.4B
Volume
28.0M
Avg. Volume
25.6M
P/E Ratio
12.075949
Dividend Yield
0.00%
Employees
461.0
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Risk & Correlation Analysis
Market Correlation
0.69
Low Correlation
Volatility
Medium (0.39)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ANIP shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.4B
Volume28.0M
P/E Ratio12.08
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 28, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025